Klemt I, Reshetnikov V, Dutta S, Bila G, Bilyy R, Cuartero I, Hidalgo A, Wünsche A, Böhm M, Wondrak M, Kunz-Schughart L, Tietze R, Beierlein F, Imhof P, Gensberger-Reigl S, Pischetsrieder M, Körber M, Jost T, Mokhir A. A concept of dual-responsive prodrugs based on oligomerization-controlled reactivity of ester groups: an improvement of cancer cells versus neutrophils selectivity of camptothecin. RSC Medicinal Chemistry 2024, 15: 1189-1197. PMID: 38665843, PMCID: PMC11042170, DOI: 10.1039/d3md00609c.Peer-Reviewed Original Research